www.tevapharm.com
Open in
urlscan Pro
45.60.155.76
Public Scan
Submitted URL: http://www.tevapharm.com/
Effective URL: https://www.tevapharm.com/
Submission: On October 01 via manual from PH — Scanned from DE
Effective URL: https://www.tevapharm.com/
Submission: On October 01 via manual from PH — Scanned from DE
Form analysis
1 forms found in the DOMGET /en/tevapharm/search-results/
<form action="/en/tevapharm/search-results/" class="gw-page-search__form" method="get" novalidate="" role="search">
<fieldset class="gw-page-search__set">
<label class="sr-only" for="sg-2d114b">Search</label>
<input id="sg-2d114b" autocomplete="off" class="gw-page-search__input" data-mobileresults="4" data-desktopresults="7" data-tabindex-collapsed="4" placeholder="type your search" aria-label="type your search" required="" type="search" value="">
<div class="gw-page-search__btn">
<button type="submit" data-tabindex-collapsed="4" class="vi-btn vi-btn-search"> Search </button>
</div>
</fieldset>
<div class="gw-page-search__clear">
<div class="gw-page-search__clear-inset">
<div class="gw-page-search__clear-btn">
<button type="reset" class="vi-btn-search vi-btn-search--clear vi-btn"> Clear </button>
</div>
</div>
</div>
</form>
Text Content
We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience. Close Skip to main content Search Search Clear Press to close the select your country window or navigate to it's content FIND MORE INFORMATION ABOUT TEVA IN YOUR LOCATION, OR CONTACT A LOCAL REPRESENTATIVE ON OUR LOCAL SITES NORTH AMERICA * Canada * United States INTERNATIONAL MARKETS * Argentina * Australia * Belarus * Brazil * Chile * China * Hong Kong SAR * India * Indonesia * Israel * Japan * Kazakhstan * Kyrgyzstan * Mexico * New Zealand * Peru * Russia * Singapore * South Africa * South Korea * Thailand * Turkey * Ukraine * Uruguay EUROPE * Austria * Belgium * Bosnia and Herzegovina * Bulgaria * Croatia * Czech Republic * Denmark * Estonia * Finland * France * Germany * Greece * Hungary * Iceland * Ireland * Italy * Latvia * Lithuania * Macedonia * Malta * Netherlands * Norway * Poland * Portugal * Romania * Serbia * Slovakia * Slovenia * Spain * Sweden * Switzerland * United Kingdom NORTH AMERICA Toggle * Canada * United States INTERNATIONAL MARKETS Toggle * Argentina * Australia * Belarus * Brazil * Chile * China * Hong Kong SAR * India * Indonesia * Israel * Japan * Kazakhstan * Kyrgyzstan * Mexico * New Zealand * Peru * Russia * Singapore * South Africa * South Korea * Thailand * Turkey * Ukraine * Uruguay EUROPE Toggle * Austria * Belgium * Bosnia and Herzegovina * Bulgaria * Croatia * Czech Republic * Denmark * Estonia * Finland * France * Germany * Greece * Hungary * Iceland * Ireland * Italy * Latvia * Lithuania * Macedonia * Malta * Netherlands * Norway * Poland * Portugal * Romania * Serbia * Slovakia * Slovenia * Spain * Sweden * Switzerland * United Kingdom Close * Investors * News & Media Select your location Search * Our Company Show Submenu * Our Purpose * Leadership and Corporate Governance Show Submenu * Corporate Officers * Board of Directors * Governance & Policy Documents * Our Values * Teva Facts & Figures * Our History * Teva’s Global Supply Chain * Compliance and Integrity As a global leader in generic medicines with a strong innovative portfolio, we are all in for better health. * Product Focus Show Submenu * Generic Medicines * Innovative Therapeutic Areas * Biopharmaceuticals * Research & Development Show Submenu * Our Pipeline * Clinical Trials * Collaborative Research & ISS * Medical Information * Consumer Healthcare * Out-Licensing Generic Pharmaceuticals * Teva api * Quality Products Quality, accessibility, and innovation, without compromise * Patients & Caregivers Show Submenu * Life Effects: Patient Stories * Caregiver Resources * Humanizing Health * Patient Safety * Antimicrobial Resistance * Clinical Trials * Our Impact Show Submenu * Healthy Future Progress Report * Access to Medicine * Protecting our Planet * Ethics & Compliance * Economic Impact * Responsible Suppliers * Community Giving Acting responsibly and ethically in all we do helps ensure our sustainability—allowing Teva to provide treatments to those who need them for years to come. * Your Career Show Submenu * What we do * Inclusion & Diversity Show Submenu * Gender Equality * Celebrating Pride at Teva * Life at Teva * Growth at Teva * Benefits & Wellbeing * Changing Industry * How we Hire * Our People Working at Teva is not just a job, it’s so much more than that. Here, you get to spend each day helping millions of people around the world enjoy healthier lives. At the same time, you’ll be joining a dedicated team, united by the strong sense that we’re building something greater than ourselves. * Contact Us Menu WE ARE ALL IN FOR BETTER HEALTH WHAT ARE THE 3 BIGGEST ELEMENTS SHAPING CLINICAL DEVELOPMENT TODAY? Eran Harary , SVP, Head of Global Early Clinical Development, identifies key trends in the Clinical development area. Discover more What are the 3 biggest elements shaping clinical development today? MEDICAL SPECIALISTS WE ALL NEED BUT NEVER SEE: SAFETY PHYSICIANS While most people consult medical specialists at some point in their lifelong healthcare journey, there is one medical specialist almost everyone relies on but we never see in a doctor’s office: safety physicians. Discover more Medical Specialists We All Need but Never See: Safety Physicians PRESS RELEASES September 30, 2024 TEVA TO HOST CONFERENCE CALL TO DISCUSS THIRD QUARTER 2024 FINANCIAL RESULTS AT 8 A.M. ET ON NOVEMBE... Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, September 23, 2024 TEVA ANNOUNCES LONG TERM EFFICACY AND SAFETY OF DEUTETRABENAZINE IN EUROPEAN PATIENTS WITH DEBILITAT... Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating M September 21, 2024 TEVA PRESENTS NEW PHASE 3 EFFICACY, SAFETY AND TOLERABILITY DATA FROM SOLARIS TRIAL EVALUATING TEV-‘... Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 ( September 21, 2024 NEW DATA PROVIDE TREATMENT INSIGHTS INTO OPTIONS FOR SWITCHING ADULT PATIENTS DIAGNOSED WITH SCHIZOP... New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophreni September 11, 2024 TEVA TO PRESENT AT THE BANK OF AMERICA 2024 GLOBAL HEALTHCARE CONFERENCE Teva to Present at the Bank of America 2024 Global Healthcare Conference August 26, 2024 TEVA TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference July 31, 2024 TEVA ANNOUNCES STRONG GROWTH IN SECOND QUARTER REVENUES MAINLY DRIVEN BY GENERICS PRODUCTS IN ALL RE... Teva Announces Strong Growth in Second Quarter Revenues mainly driven by Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance July 25, 2024 TEVA AND SANOFI ANNOUNCE ACCELERATED TIMELINE FOR ANTI-TL1A PHASE 2B PROGRAM IN PATIENTS WITH INFLAM... Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammator July 18, 2024 TEVA ANNOUNCES FIRST PHASE 3 EVIDENCE OF EFFICACY AND SAFETY OF AN ANTI-CGRP MONOCLONAL ANTIBODY IN ... Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Child July 02, 2024 TEVA TO HOST CONFERENCE CALL TO DISCUSS SECOND QUARTER 2024 FINANCIAL RESULTS AT 8 A.M. ET ON JULY 3... Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 20 September 30, 2024 TEVA TO HOST CONFERENCE CALL TO DISCUSS THIRD QUARTER 2024 FINANCIAL RESULTS AT 8 A.M. ET ON NOVEMBE... Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, September 23, 2024 TEVA ANNOUNCES LONG TERM EFFICACY AND SAFETY OF DEUTETRABENAZINE IN EUROPEAN PATIENTS WITH DEBILITAT... Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating M September 21, 2024 TEVA PRESENTS NEW PHASE 3 EFFICACY, SAFETY AND TOLERABILITY DATA FROM SOLARIS TRIAL EVALUATING TEV-‘... Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 ( September 21, 2024 NEW DATA PROVIDE TREATMENT INSIGHTS INTO OPTIONS FOR SWITCHING ADULT PATIENTS DIAGNOSED WITH SCHIZOP... New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophreni September 11, 2024 TEVA TO PRESENT AT THE BANK OF AMERICA 2024 GLOBAL HEALTHCARE CONFERENCE Teva to Present at the Bank of America 2024 Global Healthcare Conference August 26, 2024 TEVA TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference July 31, 2024 TEVA ANNOUNCES STRONG GROWTH IN SECOND QUARTER REVENUES MAINLY DRIVEN BY GENERICS PRODUCTS IN ALL RE... Teva Announces Strong Growth in Second Quarter Revenues mainly driven by Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance July 25, 2024 TEVA AND SANOFI ANNOUNCE ACCELERATED TIMELINE FOR ANTI-TL1A PHASE 2B PROGRAM IN PATIENTS WITH INFLAM... Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammator July 18, 2024 TEVA ANNOUNCES FIRST PHASE 3 EVIDENCE OF EFFICACY AND SAFETY OF AN ANTI-CGRP MONOCLONAL ANTIBODY IN ... Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Child July 02, 2024 TEVA TO HOST CONFERENCE CALL TO DISCUSS SECOND QUARTER 2024 FINANCIAL RESULTS AT 8 A.M. ET ON JULY 3... Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 20 September 30, 2024 TEVA TO HOST CONFERENCE CALL TO DISCUSS THIRD QUARTER 2024 FINANCIAL RESULTS AT 8 A.M. ET ON NOVEMBE... Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, September 23, 2024 TEVA ANNOUNCES LONG TERM EFFICACY AND SAFETY OF DEUTETRABENAZINE IN EUROPEAN PATIENTS WITH DEBILITAT... Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating M September 21, 2024 TEVA PRESENTS NEW PHASE 3 EFFICACY, SAFETY AND TOLERABILITY DATA FROM SOLARIS TRIAL EVALUATING TEV-‘... Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 ( September 21, 2024 NEW DATA PROVIDE TREATMENT INSIGHTS INTO OPTIONS FOR SWITCHING ADULT PATIENTS DIAGNOSED WITH SCHIZOP... New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophreni September 11, 2024 TEVA TO PRESENT AT THE BANK OF AMERICA 2024 GLOBAL HEALTHCARE CONFERENCE Teva to Present at the Bank of America 2024 Global Healthcare Conference August 26, 2024 TEVA TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference July 31, 2024 TEVA ANNOUNCES STRONG GROWTH IN SECOND QUARTER REVENUES MAINLY DRIVEN BY GENERICS PRODUCTS IN ALL RE... Teva Announces Strong Growth in Second Quarter Revenues mainly driven by Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance July 25, 2024 TEVA AND SANOFI ANNOUNCE ACCELERATED TIMELINE FOR ANTI-TL1A PHASE 2B PROGRAM IN PATIENTS WITH INFLAM... Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammator July 18, 2024 TEVA ANNOUNCES FIRST PHASE 3 EVIDENCE OF EFFICACY AND SAFETY OF AN ANTI-CGRP MONOCLONAL ANTIBODY IN ... Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Child July 02, 2024 TEVA TO HOST CONFERENCE CALL TO DISCUSS SECOND QUARTER 2024 FINANCIAL RESULTS AT 8 A.M. ET ON JULY 3... Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 20 View all press releases Previous Next HEALTHY FUTURE: SUSTAINABILITY AT TEVA TEVA NAMED ONE OF THE WORLD’S MOST SUSTAINABLE COMPANIES TIME magazine and data firm Statista measured how companies are living up to their promises to protect our planet. We’re honored to be recognized for our efforts and ambitions. Discover more Teva Named One of the World’s Most Sustainable Companies -------------------------------------------------------------------------------- TAKE A CLOSER LOOK AT WHAT WE DO HOW CAN WE USE AI TO MAKE MEDICINES MORE EFFICIENTLY? Discover more 3 TRENDS I’M WATCHING IN PATIENT SAFETY Discover more "I BELIEVE THAT WELLBEING STARTS WITH YOUR INNER SELF" Discover more NO MOUNTAIN TOO HIGH FOR WELLBEING Discover more TEVA’S TOP GRADUATES: FROM ACADEMIC LEARNING TO BUSINESS LEADERSHIP Discover more PIVOT TO GROWTH: THE TEVA JOURNEY Discover more WHAT TO KNOW ABOUT SCHIZOPHRENIA Discover more CHALLENGING GENDER STEREOTYPES TO DRIVE EXCELLENCE Discover more EMPOWERING PEOPLE TO TAKE BETTER CARE OF THEMSELVES Discover more 7 WAYS TEVA IS COLLABORATING TO INNOVATE Discover more CARING FOR CAREGIVERS: HEATHER’S JOURNEY WITH HD Discover more "WE SPEND A LOT OF TIME AT WORK; WE SHOULD ENJOY IT." Discover more DIVERSITY FUELS INNOVATION IN TEVA’S R&D MANAGEMENT TEAM Discover more COMPLEX GENERICS: FACTS, FIGURES AND WHO THEY BENEFIT Read more TEVA + OUR SUPPLIERS = A GREATER POSITIVE IMPACT Discover more TOOLS & RESOURCES FOR CAREGIVERS Discover more HOW CAN WE USE AI TO MAKE MEDICINES MORE EFFICIENTLY? Discover more 3 TRENDS I’M WATCHING IN PATIENT SAFETY Discover more "I BELIEVE THAT WELLBEING STARTS WITH YOUR INNER SELF" Discover more NO MOUNTAIN TOO HIGH FOR WELLBEING Discover more TEVA’S TOP GRADUATES: FROM ACADEMIC LEARNING TO BUSINESS LEADERSHIP Discover more PIVOT TO GROWTH: THE TEVA JOURNEY Discover more WHAT TO KNOW ABOUT SCHIZOPHRENIA Discover more CHALLENGING GENDER STEREOTYPES TO DRIVE EXCELLENCE Discover more EMPOWERING PEOPLE TO TAKE BETTER CARE OF THEMSELVES Discover more 7 WAYS TEVA IS COLLABORATING TO INNOVATE Discover more CARING FOR CAREGIVERS: HEATHER’S JOURNEY WITH HD Discover more "WE SPEND A LOT OF TIME AT WORK; WE SHOULD ENJOY IT." Discover more DIVERSITY FUELS INNOVATION IN TEVA’S R&D MANAGEMENT TEAM Discover more COMPLEX GENERICS: FACTS, FIGURES AND WHO THEY BENEFIT Read more TEVA + OUR SUPPLIERS = A GREATER POSITIVE IMPACT Discover more TOOLS & RESOURCES FOR CAREGIVERS Discover more HOW CAN WE USE AI TO MAKE MEDICINES MORE EFFICIENTLY? Discover more 3 TRENDS I’M WATCHING IN PATIENT SAFETY Discover more "I BELIEVE THAT WELLBEING STARTS WITH YOUR INNER SELF" Discover more NO MOUNTAIN TOO HIGH FOR WELLBEING Discover more TEVA’S TOP GRADUATES: FROM ACADEMIC LEARNING TO BUSINESS LEADERSHIP Discover more PIVOT TO GROWTH: THE TEVA JOURNEY Discover more WHAT TO KNOW ABOUT SCHIZOPHRENIA Discover more CHALLENGING GENDER STEREOTYPES TO DRIVE EXCELLENCE Discover more EMPOWERING PEOPLE TO TAKE BETTER CARE OF THEMSELVES Discover more 7 WAYS TEVA IS COLLABORATING TO INNOVATE Discover more CARING FOR CAREGIVERS: HEATHER’S JOURNEY WITH HD Discover more "WE SPEND A LOT OF TIME AT WORK; WE SHOULD ENJOY IT." Discover more DIVERSITY FUELS INNOVATION IN TEVA’S R&D MANAGEMENT TEAM Discover more COMPLEX GENERICS: FACTS, FIGURES AND WHO THEY BENEFIT Read more TEVA + OUR SUPPLIERS = A GREATER POSITIVE IMPACT Discover more TOOLS & RESOURCES FOR CAREGIVERS Discover more View all stories Previous Next CAREERS AT TEVA MAKE A DIFFERENCE TO PEOPLE'S HEALTH, EVERY DAY Working at Teva is not just a job, it’s so much more than that. Here, you get to spend each day helping millions of people around the world enjoy healthier lives. At the same time, you’ll be joining a dedicated team, united by the strong sense that we’re building something greater than ourselves Explore a Teva Career Make a difference to people's health, every day -------------------------------------------------------------------------------- LIFE EFFECTS STORIES FROM PATIENTS AND CAREGIVERS MY 7 COPING STRATEGIES FOR LIVING WITH DEPRESSION Discover more GETTING COMFORTABLE DATING WITH SCHIZOPHRENIA – SOME OF MY CHALLENGES AND WINS Discover more SURVIVAL OF THE FOCUSED: HOW TACHYCARDIA PUSHED ME TO MAKE HEART-HEALTHY LIFESTYLE CHANGES Discover more HOW I HELP MANAGE MY CHRONIC PAIN WITH EXERCISE Discover more SEASONAL ALLERGIES OR MIGRAINE? KNOW THE DIFFERENCE Discover more MANAGING CHILDBIRTH AND BREASTFEEDING WITH DEPRESSION AND ANXIETY Discover more ASTHMA MYTHS VS. PERSONAL EXPERIENCE – HOW DO THE MYTHS HOLD UP? Read more LEARNING ESSENTIAL CAREGIVER COMMUNICATION SKILLS Read more 4 THINGS EVERYONE CAN DO TO COMBAT MENTAL HEALTH STIGMA Read more 5 TIPS FOR BETTER ASTHMA CONTROL Read more ADHD AND IMPULSIVITY: 6 WAYS TO STAY IN CONTROL Read more HOW TO DISCUSS UNCOMFORTABLE TOPICS AS A CAREGIVER Read more “SAY WHAT?!” HOW TO NIP UNWANTED CANCER ADVICE IN THE BUD Read more MIGRAINE AND BRAIN FOG Read more CAREGIVER TIME MANAGEMENT – ALWAYS A WORK IN PROCESS Read more KEEPING IT SIMPLE: REDUCING HAZARDS AS HD PROGRESSES Read more THE PROBLEM WITH NOT TALKING ABOUT HEART FAILURE Read more MY 7 COPING STRATEGIES FOR LIVING WITH DEPRESSION Discover more GETTING COMFORTABLE DATING WITH SCHIZOPHRENIA – SOME OF MY CHALLENGES AND WINS Discover more SURVIVAL OF THE FOCUSED: HOW TACHYCARDIA PUSHED ME TO MAKE HEART-HEALTHY LIFESTYLE CHANGES Discover more HOW I HELP MANAGE MY CHRONIC PAIN WITH EXERCISE Discover more SEASONAL ALLERGIES OR MIGRAINE? KNOW THE DIFFERENCE Discover more MANAGING CHILDBIRTH AND BREASTFEEDING WITH DEPRESSION AND ANXIETY Discover more ASTHMA MYTHS VS. PERSONAL EXPERIENCE – HOW DO THE MYTHS HOLD UP? Read more LEARNING ESSENTIAL CAREGIVER COMMUNICATION SKILLS Read more 4 THINGS EVERYONE CAN DO TO COMBAT MENTAL HEALTH STIGMA Read more 5 TIPS FOR BETTER ASTHMA CONTROL Read more ADHD AND IMPULSIVITY: 6 WAYS TO STAY IN CONTROL Read more HOW TO DISCUSS UNCOMFORTABLE TOPICS AS A CAREGIVER Read more “SAY WHAT?!” HOW TO NIP UNWANTED CANCER ADVICE IN THE BUD Read more MIGRAINE AND BRAIN FOG Read more CAREGIVER TIME MANAGEMENT – ALWAYS A WORK IN PROCESS Read more KEEPING IT SIMPLE: REDUCING HAZARDS AS HD PROGRESSES Read more THE PROBLEM WITH NOT TALKING ABOUT HEART FAILURE Read more MY 7 COPING STRATEGIES FOR LIVING WITH DEPRESSION Discover more GETTING COMFORTABLE DATING WITH SCHIZOPHRENIA – SOME OF MY CHALLENGES AND WINS Discover more SURVIVAL OF THE FOCUSED: HOW TACHYCARDIA PUSHED ME TO MAKE HEART-HEALTHY LIFESTYLE CHANGES Discover more HOW I HELP MANAGE MY CHRONIC PAIN WITH EXERCISE Discover more SEASONAL ALLERGIES OR MIGRAINE? KNOW THE DIFFERENCE Discover more MANAGING CHILDBIRTH AND BREASTFEEDING WITH DEPRESSION AND ANXIETY Discover more ASTHMA MYTHS VS. PERSONAL EXPERIENCE – HOW DO THE MYTHS HOLD UP? Read more LEARNING ESSENTIAL CAREGIVER COMMUNICATION SKILLS Read more 4 THINGS EVERYONE CAN DO TO COMBAT MENTAL HEALTH STIGMA Read more 5 TIPS FOR BETTER ASTHMA CONTROL Read more ADHD AND IMPULSIVITY: 6 WAYS TO STAY IN CONTROL Read more HOW TO DISCUSS UNCOMFORTABLE TOPICS AS A CAREGIVER Read more “SAY WHAT?!” HOW TO NIP UNWANTED CANCER ADVICE IN THE BUD Read more MIGRAINE AND BRAIN FOG Read more CAREGIVER TIME MANAGEMENT – ALWAYS A WORK IN PROCESS Read more KEEPING IT SIMPLE: REDUCING HAZARDS AS HD PROGRESSES Read more THE PROBLEM WITH NOT TALKING ABOUT HEART FAILURE Read more View All Stories Previous Next AT TEVA, WE FOCUS ON THE THINGS THAT COUNT Watch now AT TEVA, WE STRIVE TO DELIVER QUALITY MEDICINES TO PATIENTS AROUND THE WORLD WITH INTEGRITY AND ETHICAL BUSINESS PRACTICES. WHAT WE DO IS IMPORTANT, BUT HOW WE DO IT IS JUST AS IMPORTANT. LEARN MORE: TEVA CODE OF CONDUCT SUPPLIER CODE OF CONDUCT ENVIRONMENTAL, SOCIAL AND GOVERNANCE AT TEVA ALL CORPORATE GOVERNANCE & POLICY DOCUMENTS * Contact Us * Terms of Use * Social Media Guidelines * Teva api * Medis * Sitemap * Data Privacy * Pharmacovigilance Privacy Notice * Accessibility Statement * Cookie Settings FOLLOW US * Facebook * Twitter * Linkedin * Youtube Copyright © 2024 Teva Pharmaceutical Industries Ltd. Click here to back to top YOU ARE ABOUT TO LEAVE THE TEVA PHARMACEUTICALS GLOBAL WEBSITE Close The website you are about to access may be governed by different regional policies, regulations or advertising codes. Please be sure to read the privacy policy and terms of use of the websites that you visit. Teva Pharmaceuticals is not responsible for the accuracy or compliance with laws of information on any third party websites. Do you wish to proceed? Go to site PRIVACY PREFERENCE CENTRE * YOUR PRIVACY * STRICTLY NECESSARY COOKIES * TARGETING COOKIES * FUNCTIONAL COOKIES * PERFORMANCE COOKIES YOUR PRIVACY When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. More information STRICTLY NECESSARY COOKIES Always Active These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. Cookies Details TARGETING COOKIES Targeting Cookies Inactive These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Cookies Details FUNCTIONAL COOKIES Functional Cookies Inactive These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. Cookies Details PERFORMANCE COOKIES Performance Cookies Inactive These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore may be non-directly identifiable. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Cookies Details Back Button Back Vendor Search Filter Button Consent Leg.Interest checkbox label label checkbox label label checkbox label label * View Third Party Cookies * Name cookie name Clear checkbox label label Apply Cancel Confirm My Choices Allow All COOKIES We would like to collect some of your data to enhance your browsing experience, analyse, and measure your engagement with our content. By clicking [Accept] you consent to this and to sharing this data with our partners, including to serve you more relevant ads on other websites. If you continue without accepting, this cannot take place or will be less accurate. You can change your mind at any time. To find out more about your rights, our practices, the data we collect and our partners, click here. AcceptReject AllYour Choices